Document is current
Any future updates will be listed below
-
Authors
Schmartz, Denis
Chénard, Laura
Baumann, Cedric
Fuchs-Buder, Thomas
- License Information
-
More Information
Article History
Received: 25 March 2020
Accepted: 13 July 2020
First Online: 20 July 2020
Compliance with ethical standards
:
: TFB has received payments for lectures from Merck.
: The research protocol was approved by the institutional review committee (Comité de Protection des Personnes EST III, N°2014-A00540-47), and registered at clinicaltrials.gov (NCT 02880787) before enrolment of the first patient.
: All patients gave written informed consent and all clinical data were obtained in our department. Exclusion criteria were hypersensitivity to succinylcholine or any other of the drugs used during this study, contraindication to succinylcholine, refusal to participate, and the absence of written informed consent. This study is reported according to the STROBE statement.
